Literature DB >> 24867094

Crebanine, an aporphine alkaloid, sensitizes TNF-α-induced apoptosis and suppressed invasion of human lung adenocarcinoma cells A549 by blocking NF-κB-regulated gene products.

Supachai Yodkeeree1, Wilart Pompimon, Pornngarm Limtrakul.   

Abstract

Crebanine is an alkaloid known to exhibit anticancer, but its mechanism is not well understood. Besides, the nuclear factor-kappa B (NF-κB) transcription factor has been correlated with inflammation, carcinogenesis, tumor cell survival, invasion, and angiogenesis. In this study, we investigated the effects of crebanine on tumor necrosis factor alpha (TNF-α)-induced NF-κB activation and the expression of NF-κB-regulated gene products. We found that crebanine reduced the cell proliferation of lung, ovarian, and breast cancer cells. Crebanine also potentiated TNF-α-induced apoptosis which correlated with the suppression of the gene products linked to cell survival, B cell lymphoma-extra large, and proliferation, cyclin D1. In addition, crebanine affected TNF-α-induced activation of caspase-8, caspase-3, and poly(ADP-ribose) polymerase cleavage, indicating that the apoptotic effects of TNF-α were enhanced by crebanine. Moreover, crebanine reduced TNF-α-induced A549 cell invasion and migration. Furthermore, crebanine suppressed the TNF-α-mediated expression of proteins that involved cancer cell invasion (matrix metalloproteinase 9 urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and intercellular adhesion molecule 1) and angiogenesis (COX-2 and VEGF), all of which are known to be regulated by NF-κB. We also demonstrated that TNF-α induced NF-κB DNA-binding activity, which was inhibited by crebanine. Moreover, crebanine suppressed the TNF-α-induced degradation of inhibitor of NF-κB alpha (IκBa), which led to reduced NF-κB translocation to the nucleus. Taken together, our results demonstrated that crebanine reduced TNF-α-induced cancer cell proliferation, invasion, and survival by suppressing NF-κB activity and expression profile of its downstream genes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867094     DOI: 10.1007/s13277-014-1998-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  47 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer.

Authors:  Shishir Shishodia; Bharat B Aggarwal
Journal:  Cancer Treat Res       Date:  2004

Review 3.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion.

Authors:  Yasunari Takada; Akira Murakami; Bharat B Aggarwal
Journal:  Oncogene       Date:  2005-10-20       Impact factor: 9.867

5.  Role of ICAM1 in invasion of human breast cancer cells.

Authors:  Caridad Rosette; Richard B Roth; Paul Oeth; Andreas Braun; Stefan Kammerer; Jonas Ekblom; Mikhail F Denissenko
Journal:  Carcinogenesis       Date:  2005-03-17       Impact factor: 4.944

6.  NF-kappaB inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen species.

Authors:  Jeong-Ah Kim; Edward K Lau; Li Pan; Esperanza J Carcache De Blanco
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

7.  Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis.

Authors:  Hong Ri Jin; Song Zhu Jin; Xing Fu Cai; Donghao Li; Xue Wu; Ji Xing Nan; Jung Joon Lee; Xuejun Jin
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

8.  Breaking the 'harmony' of TNF-α signaling for cancer treatment.

Authors:  S P Sasi; X Yan; H Enderling; D Park; H-Y Gilbert; C Curry; C Coleman; L Hlatky; G Qin; R Kishore; D A Goukassian
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

9.  Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA.

Authors:  Supachai Yodkeeree; Wittaya Chaiwangyen; Spiridione Garbisa; Pornngarm Limtrakul
Journal:  J Nutr Biochem       Date:  2008-05-20       Impact factor: 6.048

10.  SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis.

Authors:  Yaopeng Wang; Bin Yue; Xuyi Yu; Zhan Wang; Mingzhao Wang
Journal:  World J Surg Oncol       Date:  2013-01-22       Impact factor: 2.754

View more
  4 in total

1.  Cyanidin-3-O-glucoside and Peonidin-3-O-glucoside-Rich Fraction of Black Rice Germ and Bran Suppresses Inflammatory Responses from SARS-CoV-2 Spike Glycoprotein S1-Induction In Vitro in A549 Lung Cells and THP-1 Macrophages via Inhibition of the NLRP3 Inflammasome Pathway.

Authors:  Warathit Semmarath; Sariya Mapoung; Sonthaya Umsumarng; Punnida Arjsri; Kamonwan Srisawad; Pilaiporn Thippraphan; Supachai Yodkeeree; Pornngarm Dejkriengkraikul
Journal:  Nutrients       Date:  2022-06-30       Impact factor: 6.706

2.  Kanglaite inhibits EMT caused by TNF-α via NF-κΒ inhibition in colorectal cancer cells.

Authors:  Guiling Shi; Xiaoli Zheng; Shiwu Zhang; Xiaojing Wu; Fei Yu; Yijia Wang; Fei Xing
Journal:  Oncotarget       Date:  2017-12-22

3.  Resveratrol raises in vitro anticancer effects of paclitaxel in NSCLC cell line A549 through COX-2 expression.

Authors:  Fanhua Kong; Runqi Zhang; Xudong Zhao; Guanlin Zheng; Zhou Wang; Peng Wang
Journal:  Korean J Physiol Pharmacol       Date:  2017-08-22       Impact factor: 2.016

4.  Exogenous C₈-Ceramide Induces Apoptosis by Overproduction of ROS and the Switch of Superoxide Dismutases SOD1 to SOD2 in Human Lung Cancer Cells.

Authors:  Yuli C Chang; Yao Fong; Eing-Mei Tsai; Ya-Gin Chang; Han Lin Chou; Chang-Yi Wu; Yen-Ni Teng; Ta-Chih Liu; Shyng-Shiou Yuan; Chien-Chih Chiu
Journal:  Int J Mol Sci       Date:  2018-10-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.